Report overview
Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.
This report contains market size and forecasts of Viral Vector Vaccines in global, including the following market information:
Global Viral Vector Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Viral Vector Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Viral Vector Vaccines companies in 2021 (%)
The global Viral Vector Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adenovirus Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral Vector Vaccines include Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio, Creative Biogene, GE Healthcare, Pfizer and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vector Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, by Type, 2021 (%)
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others
Global Viral Vector Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Viral Vector Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vector Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Viral Vector Vaccines revenues share in global market, 2021 (%)
Key companies Viral Vector Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Viral Vector Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Bioscience Laboratories
Boehringer Ingelheim
Brammer Bio
Creative Biogene
GE Healthcare
Pfizer
Sanofi
